TACOS 2019 Spring Conference

Fri, April 12, 2019
1:45 PM to 7:30 PM (US Mountain Standard Time)

Drastic changes in healthcare reform and medical research are requiring oncology practices to think outside the box in order to maximize operations while continuing to improve cancer care delivery. Register today to experience a collaborative forum for exploring the more exciting clinical advances in cancer treatment, unique perspectives on the impact of national policies on state-level initiatives, and more!

Pointe Hilton Tapatio Cliffs

11111 N. 7th Street
Phoenix, AZ 85020

There is no room block associated with this conference. If you would like to reserve a room, please contact the hotel directly.

CME/CE Accreditation and Credit Designation Statements

The Institute for Medical and Nursing Education, Inc. (IMNE), is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians. IMNE designates this live activity for 4.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses/Nurse Practitioners
IMNE is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s (ANCC’s) Commission on Accreditation. This educational program provides 4.25 contact hours of continuing education credit.

Upcoming Webinar: Key Takeaways from 2018 ASH

Wednesday, May 8, 1:00 - 2:00 PM EST

Featuring William Donnellan, MD, Sarah Cannon, this webinar will highlight stand-out abstracts presented at the latest ASH Annual Meeting. Participants will learn about exciting research developments in hematology-oncology and discover how these updates may be translated into cutting-edge patient care.

William DonnellanGuest Speaker: William Donnellan, MD
Director, Acute Leukemia/Myelodysplastic Syndromes Research
Sarah Cannon Research Institute/Tennessee Oncology

Dr. Donnellan joined Sarah Cannon in 2014 as an investigator of hematologic malignancies with expertise in treating patients with a variety of blood cancers—specifically myeloid stem cell disorders including the myelodysplastic syndromes, acute myeloid leukemia, and the myeloproliferative neoplasms.

In his current role, Dr. Donnellan oversees research surrounding myeloid stem cell disorders for the Sarah Cannon program in Nashville and Sarah Cannon Blood Cancer Network. The Sarah Cannon Blood Cancer Network is one of the largest providers of hematopoietic cell transplantation, and conducts more than 1,000 transplants annually through six FACT-accredited transplant centers.

Dr. Donnellan is board certified in internal medicine, hematology and medical oncology. Additionally, he is an associate with Tennessee Oncology, PLLC.


1801 Research Boulevard Suite 400
Rockville, MD 20850
Tel: 301.984.9496 | Fax: 301.770.1949
Email Us